Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Apr;25(4):465–475. doi: 10.1111/j.1365-2125.1988.tb03331.x

The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

G I Murray 1, T S Barnes 1, H F Sewell 1, S W Ewen 1, W T Melvin 1, M D Burke 1
PMCID: PMC1387809  PMID: 3289600

Abstract

1. The localisation and distribution of cytochrome P-450 in human tissues has been studied by immunocytochemistry using a monoclonal antibody to a major form of human hepatic cytochrome P-450, P-450hA7, which is closely related to cytochromes P-450 HLp and P-450NF. 2. Strong immunoreactivity was identified in hepatocytes, columnar absorptive epithelial cells of the small intestine, polymorphonuclear leucocytes and their precursors in the bone marrow, and in mast cells. 3. Weak immunoreactivity was present in the proximal tubules of the kidney, pancreatic acini, gall bladder epithelium, squamous epithelium and sebaceous glands of the skin, interstitial cells of the testis and luteal cells of the ovary. 4. Immunoreactivity could not be demonstrated in the adrenal gland, placenta, colonic epithelium and alveolar type II cells and Clara cells of the lung.

Full text

PDF
467

Images in this article

468Figure 1
on p.468
469Figure 2
on p.469
470Figure 3
on p.470
471Figure 4
on p.471
472p472-a
on p.472
473Figure 5
on p.473

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adesnik M., Atchison M. Genes for cytochrome P-450 and their regulation. CRC Crit Rev Biochem. 1986;19(3):247–305. doi: 10.3109/10409238609084657. [DOI] [PubMed] [Google Scholar]
  2. Autrup H., Grafstrom R. C., Brugh M., Lechner J. F., Haugen A., Trump B. F., Harris C. C. Comparison of benzo(a)pyrene metabolism in bronchus, esophagus, colon, and duodenum from the same individual. Cancer Res. 1982 Mar;42(3):934–938. [PubMed] [Google Scholar]
  3. Barnes T. S., Shaw P. M., Burke M. D., Melvin W. T. Monoclonal antibodies against human cytochrome P-450 recognizing different pregnenolone 16 alpha-carbonitrile-inducible rat cytochromes P-450. Biochem J. 1987 Nov 15;248(1):301–304. doi: 10.1042/bj2480301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beaune P. H., Umbenhauer D. R., Bork R. W., Lloyd R. S., Guengerich F. P. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8064–8068. doi: 10.1073/pnas.83.21.8064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bonkovsky H. L., Hauri H. P., Marti U., Gasser R., Meyer U. A. Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital. Gastroenterology. 1985 Feb;88(2):458–467. doi: 10.1016/0016-5085(85)90507-4. [DOI] [PubMed] [Google Scholar]
  6. Boyd M. R. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature. 1977 Oct 20;269(5630):713–715. doi: 10.1038/269713a0. [DOI] [PubMed] [Google Scholar]
  7. Burke M. D., Mayer R. T., Kouri R. E. 3-methylcholanthrene-induced monooxygenase (O-deethylation) activity of human lymphocytes. Cancer Res. 1977 Feb;37(2):460–463. [PubMed] [Google Scholar]
  8. Burke M. D., Orrenius S. Isolation and comparison of endoplasmic reticulum membranes and their mixed function oxidase activities from mammalian extrahepatic tissues. Pharmacol Ther. 1979;7(3):549–599. doi: 10.1016/0163-7258(79)90042-1. [DOI] [PubMed] [Google Scholar]
  9. Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol. 1985 Sep 15;34(18):3337–3345. doi: 10.1016/0006-2952(85)90355-7. [DOI] [PubMed] [Google Scholar]
  10. Chung B. C., Picado-Leonard J., Haniu M., Bienkowski M., Hall P. F., Shively J. E., Miller W. L. Cytochrome P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci U S A. 1987 Jan;84(2):407–411. doi: 10.1073/pnas.84.2.407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cinti D. L., Feinstein M. B. Platelet cytochrome P450: a possible role in arachidonate-induced aggregation. Biochem Biophys Res Commun. 1976 Nov 8;73(1):171–179. doi: 10.1016/0006-291x(76)90512-x. [DOI] [PubMed] [Google Scholar]
  12. Cohen G. M., Grafstrom R. C., Gibby E. M., Smith L., Autrup H., Harris C. C. Metabolism of benzo(a)pyrene and 1-naphthol in cultured human tumorous and nontumorous colon. Cancer Res. 1983 Mar;43(3):1312–1315. [PubMed] [Google Scholar]
  13. Devereux T. R., Massey T. E., Van Scott M. R., Yankaskas J., Fouts J. R. Xenobiotic metabolism in human alveolar type II cells isolated by centrifugal elutriation and density gradient centrifugation. Cancer Res. 1986 Oct;46(10):5438–5443. [PubMed] [Google Scholar]
  14. Ding X. X., Koop D. R., Crump B. L., Coon M. J. Immunochemical identification of cytochrome P-450 isozyme 3a (P-450ALC) in rabbit nasal and kidney microsomes and evidence for differential induction by alcohol. Mol Pharmacol. 1986 Oct;30(4):370–378. [PubMed] [Google Scholar]
  15. Finnen M. J., Shuster S., Lawrence C. M., Rawlins M. D. Aryl hydrocarbon hydroxylase activity and psoriasis. Biochem Pharmacol. 1983 Jun 1;32(11):1707–1711. doi: 10.1016/0006-2952(83)90113-2. [DOI] [PubMed] [Google Scholar]
  16. Foster J. R., Elcombe C. R., Boobis A. R., Davies D. S., Sesardic D., McQuade J., Robson R. T., Hayward C., Lock E. A. Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 c. Biochem Pharmacol. 1986 Dec 15;35(24):4543–4554. doi: 10.1016/0006-2952(86)90777-x. [DOI] [PubMed] [Google Scholar]
  17. Fujino T., Park S. S., West D., Gelboin H. V. Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies. Proc Natl Acad Sci U S A. 1982 Jun;79(12):3682–3686. doi: 10.1073/pnas.79.12.3682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gram T. E., Okine L. K., Gram R. A. The metabolism of xenobiotics by certain extrahepatic organs and its relation to toxicity. Annu Rev Pharmacol Toxicol. 1986;26:259–291. doi: 10.1146/annurev.pa.26.040186.001355. [DOI] [PubMed] [Google Scholar]
  19. Guengerich F. P., Dannan G. A., Wright S. T., Martin M. V., Kaminsky L. S. Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. Biochemistry. 1982 Nov 9;21(23):6019–6030. doi: 10.1021/bi00266a045. [DOI] [PubMed] [Google Scholar]
  20. Haglund L., Köhler C., Haaparanta T., Goldstein M., Gustafsson J. A. Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones. Nature. 1984 Jan 19;307(5948):259–262. doi: 10.1038/307259a0. [DOI] [PubMed] [Google Scholar]
  21. Haurand M., Ullrich V. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. J Biol Chem. 1985 Dec 5;260(28):15059–15067. [PubMed] [Google Scholar]
  22. Kawabata T. T., Wick D. G., Guengerich F. P., Baron J. Immunohistochemical localization of carcinogen-metabolizing enzymes within the rat and hamster exocrine pancreas. Cancer Res. 1984 Jan;44(1):215–223. [PubMed] [Google Scholar]
  23. McLemore T. L., Martin R. R., Pickard L. R., Springer R. R., Wray N. P., Toppell K. L., Mattox K. L., Guinn G. A., Cantrell E. T., Busbee D. L. Analysis of aryl hydrocarbon hydroxylase activity in human lung tissue, pulmonary macrophages, and blood lymphocytes. Cancer. 1978 Jun;41(6):2292–2300. doi: 10.1002/1097-0142(197806)41:6<2292::aid-cncr2820410630>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  24. Mendelson C. R., Wright E. E., Evans C. T., Porter J. C., Simpson E. R. Preparation and characterization of polyclonal and monoclonal antibodies against human aromatase cytochrome P-450 (P-450AROM), and their use in its purification. Arch Biochem Biophys. 1985 Dec;243(2):480–491. doi: 10.1016/0003-9861(85)90525-9. [DOI] [PubMed] [Google Scholar]
  25. Mungikar A. M., Gothoskar B. P. Partial purification of cytochrome P-450 from human normal granulocytes. Res Commun Chem Pathol Pharmacol. 1986 Feb;51(2):281–284. [PubMed] [Google Scholar]
  26. Okita R. T., Jakobsson S. W., Prough R. A., Masters B. S. Lauric acid hydroxylation in human liver and kidney cortex microsomes. Biochem Pharmacol. 1979 Dec 1;28(23):3385–3390. doi: 10.1016/0006-2952(79)90077-7. [DOI] [PubMed] [Google Scholar]
  27. Reed C. J., Lock E. A., De Matteis F. NADPH: cytochrome P-450 reductase in olfactory epithelium. Relevance to cytochrome P-450-dependent reactions. Biochem J. 1986 Dec 1;240(2):585–592. doi: 10.1042/bj2400585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Serabjit-Singh C. J., Wolf C. R., Philpot R. M., Plopper C. G. Cytochrome p-450: localization in rabbit lung. Science. 1980 Mar 28;207(4438):1469–1470. doi: 10.1126/science.6767272. [DOI] [PubMed] [Google Scholar]
  29. Shak S., Goldstein I. M. Carbon monoxide inhibits omega-oxidation of leukotriene B4 by human polymorphonuclear leukocytes: evidence that catabolism of leukotriene B4 is mediated by a cytochrome P-450 enzyme. Biochem Biophys Res Commun. 1984 Sep 17;123(2):475–481. doi: 10.1016/0006-291x(84)90255-9. [DOI] [PubMed] [Google Scholar]
  30. Shak S., Goldstein I. M. Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P-450. J Clin Invest. 1985 Sep;76(3):1218–1228. doi: 10.1172/JCI112077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Voigt J. M., Guengerich F. P., Baron J. Localization of a cytochrome P-450 isozyme (cytochrome P-450 PB-B) and NADPH-cytochrome P-450 reductase in rat nasal mucosa. Cancer Lett. 1985 Jul;27(3):241–247. doi: 10.1016/0304-3835(85)90180-6. [DOI] [PubMed] [Google Scholar]
  32. Voutilainen R., Tapanainen J., Chung B. C., Matteson K. J., Miller W. L. Hormonal regulation of P450scc (20,22-desmolase) and P450c17 (17 alpha-hydroxylase/17,20-lyase) in cultured human granulosa cells. J Clin Endocrinol Metab. 1986 Jul;63(1):202–207. doi: 10.1210/jcem-63-1-202. [DOI] [PubMed] [Google Scholar]
  33. Walther B., Ghersi-Egea J. F., Minn A., Siest G. Subcellular distribution of cytochrome P-450 in the brain. Brain Res. 1986 Jun 11;375(2):338–344. doi: 10.1016/0006-8993(86)90754-7. [DOI] [PubMed] [Google Scholar]
  34. Watkins P. B., Wrighton S. A., Maurel P., Schuetz E. G., Mendez-Picon G., Parker G. A., Guzelian P. S. Identification of an inducible form of cytochrome P-450 in human liver. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6310–6314. doi: 10.1073/pnas.82.18.6310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. le Provost E., Cresteil T., Columelli S., Leroux J. P. Immunological and enzymatic comparison of hepatic cytochrome P-450 fractions from phenobarbital-, 3-methylcholanthrene-, beta-naphthoflavone- and 2,3,7,8- tetrachlorodibenzo-p-dioxin-treated rats. Biochem Pharmacol. 1983 Jun 1;32(11):1673–1682. doi: 10.1016/0006-2952(83)90108-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES